prose-writer
Write `output/DRAFT.md` (or `output/SNAPSHOT.md`) from an approved outline and evidence packs, using only verified citation keys from `citations/ref.bib`. **Trigger**: write draft, prose writer, snapshot, survey writing, 写综述, 生成草稿, section-by-section drafting. **Use when**: structure is approved (`DECISIONS.md` has `Approve C2`) and evidence packs exist (`outline/subsection_briefs.jsonl`, `outline/evidence_drafts.jsonl`). **Skip if**: approvals are missing, or evidence packs are incomplete / scaffolded (missing-fields, TODO markers). **Network**: none. **Guardrail**: do not invent facts or citations; only cite keys present in `citations/ref.bib`; avoid pipeline-jargon leakage in final prose.
Installation
Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.
View source ↗GuidesSkill instructions
Features and purpose
Write `output/DRAFT.md` (or `output/SNAPSHOT.md`) from an approved outline and evidence packs, using only verified citation keys from `citations/ref.bib`. **Trigger**: write draft, prose writer, snapshot, survey writing, 写综述, 生成草稿, section-by-section drafting. **Use when**: structure is approved (`DECISIONS.md` has `Approve C2`) and evidence packs exist (`outline/subsection_briefs.jsonl`, `outline/evidence_drafts.jsonl`). **Skip if**: approvals are missing, or evidence packs are incomplete / scaffolded (missing-fields, TODO markers). **Network**: none. **Guardrail**: do not invent facts or citations; only cite keys present in `citations/ref.bib`; avoid pipeline-jargon leakage in final prose.
Quick start
Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.
Guides ↗Examples
Read the usage examples in the source repository.
View source ↗Source history
- Indexed on
- 2026-01-20
- Index updated
- 2026-02-07
- Branch
- main
Index and sync dates describe this directory. View the source repository for code history.
GitHub ↗chat Comments (0)
Sign in to join the discussion and leave a comment.
No comments yet. Be the first to share your thoughts!